Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amplify Surgical markets commercialized minimally invasive surgical platforms for lumbar spine surgery, including the dualPortal endoscopic system and the dualX dual expanding interbody fusion system, with positive clinical data reported regarding improved flexibility, visualization, and patient outcomes, and more than 1,000 levels treated with the dualX system as of 2021[2][3][4][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amplify Surgical.